Jean-Jacques Parienti

Jean-Jacques Parienti

Auto-generated profile, based on publicly available information

Jean-Jacques Parienti

Department of Clinical Research, Caen University Hospital , Caen

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2015 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
JPJean-Jacques Parienti
Jean-Jacques Parienti
Nicolas MongardonNicolas Mongardon
Nicolas Mongardon
Bruno MégarbaneBruno Mégarbane
Bruno Mégarbane
JMJean-Paul Mira
Jean-Paul Mira
PKPierre Kalfon
Pierre Kalfon
DCDamien du Cheyron
Damien du Cheyron
Three anatomical sites are commonly used to insert central venous catheters, but insertion at each site has the potential for major complications.

28 May 2008 in JAMA
Verified
Journal Article
Closed access
PDF file
JPJean-Jacques Parienti
Jean-Jacques Parienti
MTMarina Thirion
Marina Thirion
Bruno MégarbaneBruno Mégarbane
Bruno Mégarbane
BSBertrand Souweine
Bertrand Souweine
AOAbdelali Ouchikhe
Abdelali Ouchikhe
NTNicolas Terzi
Nicolas Terzi
Research from JAMA — Femoral vs Jugular Venous Catheterization and Risk of Nosocomial Events in Adults Requiring Acute Renal Replacement Therapy — A Randomized Controlled Trial

1 January 2020 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
jean-francois timsitjean-francois timsit
jean-francois timsit
JBJulien Baleine
Julien Baleine
LBLouis Bernard
Louis Bernard
SCSilvia Calvino-Gunther
Silvia Calvino-Gunther
Michel DARMONMichel DARMON
Michel DARMON
VMVirginie Maxime
Virginie Maxime
The French Society of Intensive Care Medicine (SRLF), jointly with the French-Speaking Group of Paediatric Emergency Rooms and Intensive Care Units (GFRUP) and the French-Speaking Association of Paediatric Surgical Intensivists (ADARPEF), worked out guidelines for the management of central venous catheters (CVC), arterial catheters and dialysis catheters in intensive care unit. For adult patients: Using GRADE methodology, 36 recommendations for an improved catheter management were produced by the 22 experts. Recommendations regarding catheter-related infections’ prevention included the preferential use of subclavian central vein (GRADE 1), a one-step skin disinfection(GRADE 1) using 2% chlorhexidine (CHG)-alcohol (GRADE 1), and the implementation of a quality of care improvement program. Antiseptic- or antibiotic-impregnated CVC should likely not be used (GRADE 2, for children and adults). Catheter dressings should likely not be changed before the 7th day, except when the dressing gets detached, soiled or impregnated with blood (GRADE 2− adults). CHG dressings should likely be used (GRADE 2+). For adults and children, ultrasound guidance should be used to reduce mechanical complications in case of internal jugular access (GRADE 1), subclavian access (Grade 2) and femoral venous, arterial radial and femoral access (Expert opinion). For children, an ultrasound-guided supraclavicular approach of the brachiocephalic vein was recommended to reduce the number of attempts for cannulation and mechanical complications. Based on scarce publications on diagnostic and therapeutic strategies and on their experience (expert opinion), the panel proposed definitions, and therapeutic strategies.

15 February 2009 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JPJean‐Jacques Parienti
Jean‐Jacques Parienti
DBDavid R. Bangsberg
David R. Bangsberg
RVRenaud Verdon
Renaud Verdon
EGEdward M. Gardner
Edward M. Gardner
Once-daily regimens of antiretroviral therapy are simpler than other regimens, but whether such regimens are associated with better adherence to trea

24 February 2017 in Critical Care
Verified
Journal Article
Open access
PDF file
HGHarm-Jan de Grooth
Harm-Jan de Grooth
IGIrma L. Geenen
Irma L. Geenen
AGArmand R. Girbes
Armand R. Girbes
JVJean-Louis Vincent
Jean-Louis Vincent
JPJean-Jacques Parienti
Jean-Jacques Parienti
HSHeleen M Oudemans-van Straaten
Heleen M Oudemans-van Straaten
The sequential organ failure assessment score (SOFA) is increasingly used as an endpoint in intensive care randomized controlled trials (RCTs). Although serially measured SOFA is independently associated with mortality in observational cohorts, the association between treatment effects on SOFA vs. effects on mortality has not yet been quantified in RCTs. The aim of this study was to quantify the relationship between SOFA and mortality in RCTs and to identify which SOFA derivative best reflects between-group mortality differences. The review protocol was prospectively registered (Prospero CRD42016034014). We performed a literature search (up to May 1, 2016) for RCTs reporting both SOFA and mortality, and analyzed between-group differences in these outcomes. Treatment effects on SOFA and mortality were calculated as the between-group SOFA standardized difference and log odds ratio (OR), respectively. We used random-effects meta-regression to (1) quantify the linear relationship between RCT treatment effects on mortality (logOR) and SOFA (i.e. responsiveness) and (2) quantify residual heterogeneity (i.e. consistency, expressed as I 2). Of 110 eligible RCTs, 87 qualified for analysis. Using all RCTs, SOFA was significantly associated with mortality (slope = 0.49 (95% CI 0.17; 0.82), p = 0.006, I 2 = 5%); the overall mortality effect explained by SOFA score (R 2) was 9%. Fifty-eight RCTs used Fixed-day SOFA as an endpoint (i.e. the score on a fixed day after randomization), 25 studies used Delta SOFA as an endpoint (i.e. the trajectory from baseline score) and 15 studies used other SOFA derivatives as an endpoint. Fixed-day SOFA was not significantly associated with mortality (slope = 0.35 (95% CI −0.04; 0.75), p = 0.08, I 2 = 12%) and explained 3% of the overall mortality effect (R 2). Delta SOFA was significantly associated with mortality (slope = 0.70 (95% CI 0.26; 1.14), p = 0.004, I 2 = 0%) and explained 32% of the overall mortality effect (R 2). Treatment effects on Delta SOFA appear to be reliably and consistently associated with mortality in RCTs. Fixed-day SOFA was the most frequently reported outcome among the reviewed RCTs, but was not significantly associated with mortality. Based on this study, we recommend using Delta SOFA rather than Fixed-day SOFA as an endpoint in future RCTs.

1 May 2004 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JPJean-Jacques Parienti
Jean-Jacques Parienti
VMVéronique Massari
Véronique Massari
DDDiane Descamps
Diane Descamps
AVAstrid Vabret
Astrid Vabret
EBElisabeth Bouvet
Elisabeth Bouvet
RVRenaud Verdon
Renaud Verdon
Resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) increases with the wider use of this class of antiretroviral therapy. The assoc